|
ZNF507 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.614200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.939070E-03 |
| Normal-vs-Stage2 |
7.078200E-01 |
| Normal-vs-Stage3 |
7.352400E-01 |
| Normal-vs-Stage4 |
7.955400E-01 |
| Stage1-vs-Stage2 |
9.174000E-02 |
| Stage1-vs-Stage3 |
1.055870E-03 |
| Stage1-vs-Stage4 |
5.541800E-03 |
| Stage2-vs-Stage3 |
5.159600E-01 |
| Stage2-vs-Stage4 |
5.769600E-01 |
| Stage3-vs-Stage4 |
9.678800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.937500E-02 |
| Normal-vs-AfricanAmerican |
2.410800E-01 |
| Normal-vs-Asian |
6.897100E-03 |
| Caucasian-vs-AfricanAmerican |
1.920460E-02 |
| Caucasian-vs-Asian |
1.236620E-01 |
| AfricanAmerican-vs-Asian |
7.625000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.155200E-01 |
| Normal-vs-Female |
5.296100E-02 |
| Male-vs-Female |
3.106600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.375200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.212160E-02 |
| Normal-vs-Age(61-80Yrs) |
4.114200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.660400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.569200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.338800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.303400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.468000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.674200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.818950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.841800E-03 |
| Normal-vs-Grade 2 |
1.401990E-03 |
| Normal-vs-Grade 3 |
5.292000E-01 |
| Normal-vs-Grade 4 |
7.336300E-02 |
| Grade 1-vs-Grade 2 |
4.436600E-01 |
| Grade 1-vs-Grade 3 |
4.198400E-02 |
| Grade 1-vs-Grade 4 |
1.864600E-03 |
| Grade 2-vs-Grade 3 |
3.342900E-03 |
| Grade 2-vs-Grade 4 |
3.4422000000367E-06 |
| Grade 3-vs-Grade 4 |
1.510330E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.00770000028328E-07 |
| Normal-vs-ccB subtype |
5.640800E-01 |
| ccA subtype-vs-ccB subtype |
4.04080002791574E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.238960E-01 |
| Normal-vs-N1 |
2.617000E-01 |
| N0-vs-N1 |
1.419150E-01 |
|
|
